EU approves half-unit insulin pen from Sanofi

10/13/2013 | MedGadget.com

European regulators have granted Sanofi CE mark approval for its JuniorSTAR insulin pen, designed for use in type 1 diabetes patients 6 to 18 years of age. The reusable device supports half-unit dosing increments and works with Insuman, Lantus and Apidra, allowing more insulin dosing flexibility for health care providers.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA